array:23 [
  "pii" => "S2173572714000381"
  "issn" => "21735727"
  "doi" => "10.1016/j.medine.2013.04.004"
  "estado" => "S300"
  "fechaPublicacion" => "2014-06-01"
  "aid" => "594"
  "copyright" => "Elsevier España, S.L. and SEMICYUC"
  "copyrightAnyo" => "2012"
  "documento" => "article"
  "crossmark" => 0
  "subdocumento" => "fla"
  "cita" => "Med Intensiva. 2014;38:278-82"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 2117
    "formatos" => array:3 [
      "EPUB" => 171
      "HTML" => 1223
      "PDF" => 723
    ]
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S2173572714000393"
    "issn" => "21735727"
    "doi" => "10.1016/j.medine.2013.06.003"
    "estado" => "S300"
    "fechaPublicacion" => "2014-06-01"
    "aid" => "605"
    "copyright" => "Elsevier España, S.L. and SEMICYUC"
    "documento" => "article"
    "crossmark" => 0
    "subdocumento" => "fla"
    "cita" => "Med Intensiva. 2014;38:288-96"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2120
      "formatos" => array:3 [
        "EPUB" => 153
        "HTML" => 1270
        "PDF" => 697
      ]
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original</span>"
      "titulo" => "External validation of the Simplified Acute Physiology Score &#40;SAPS&#41; 3 in Spain"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "288"
          "paginaFinal" => "296"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Validaci&#243;n externa de la puntuaci&#243;n de fisiolog&#237;a aguda simplificada &#40;SAPS&#41; 3 en Espa&#241;a"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0020"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 2580
              "Ancho" => 1558
              "Tamanyo" => 109036
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">ROC curve&#46; Discrimination for Simplified Acute Physiology Score 3 model tested using the area under the Receiver Operating Characteristics curve &#40;ROC area&#41;&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "C&#46; L&#243;pez-Caler, M&#46; Garc&#237;a-Delgado, J&#46; Carpio-Sanz, J&#46; &#193;lvarez-Rodr&#237;guez, E&#46; Aguilar-Alonso, E&#46; Castillo-Lorente, J&#46;E&#46; Barrueco-Francioni, R&#46; Rivera-Fern&#225;ndez"
          "autores" => array:8 [
            0 => array:2 [
              "nombre" => "C&#46;"
              "apellidos" => "L&#243;pez-Caler"
            ]
            1 => array:2 [
              "nombre" => "M&#46;"
              "apellidos" => "Garc&#237;a-Delgado"
            ]
            2 => array:2 [
              "nombre" => "J&#46;"
              "apellidos" => "Carpio-Sanz"
            ]
            3 => array:2 [
              "nombre" => "J&#46;"
              "apellidos" => "&#193;lvarez-Rodr&#237;guez"
            ]
            4 => array:2 [
              "nombre" => "E&#46;"
              "apellidos" => "Aguilar-Alonso"
            ]
            5 => array:2 [
              "nombre" => "E&#46;"
              "apellidos" => "Castillo-Lorente"
            ]
            6 => array:2 [
              "nombre" => "J&#46;E&#46;"
              "apellidos" => "Barrueco-Francioni"
            ]
            7 => array:2 [
              "nombre" => "R&#46;"
              "apellidos" => "Rivera-Fern&#225;ndez"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173572714000393?idApp=WMIE"
    "url" => "/21735727/0000003800000005/v1_201406130020/S2173572714000393/v1_201406130020/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S2173572714000332"
    "issn" => "21735727"
    "doi" => "10.1016/j.medine.2013.04.003"
    "estado" => "S300"
    "fechaPublicacion" => "2014-06-01"
    "aid" => "596"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46; and SEMICYUC"
    "documento" => "article"
    "crossmark" => 0
    "subdocumento" => "fla"
    "cita" => "Med Intensiva. 2014;38:271-7"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 3804
      "formatos" => array:3 [
        "EPUB" => 172
        "HTML" => 2758
        "PDF" => 874
      ]
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original</span>"
      "titulo" => "Acute renal failure according to the RIFLE and AKIN criteria&#58; A multicenter study"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "271"
          "paginaFinal" => "277"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Insuficiencia renal aguda seg&#250;n RIFLE y AKIN&#58; estudio multic&#233;ntrico"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 971
              "Ancho" => 1547
              "Tamanyo" => 70390
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">Acute renal failure according to the AKIN and RIFLE classifications&#44; and both classifications jointly&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "G&#46; Salgado, M&#46; Landa, D&#46; Masevicius, S&#46; Gianassi, J&#46;E&#46; San-Rom&#225;n, L&#46; Silva, M&#46; Gimenez, O&#46; Tejerina, P&#46; D&#237;az-Cisneros, F&#46; Ciccioli, J&#46;L&#46; do Pico"
          "autores" => array:11 [
            0 => array:2 [
              "nombre" => "G&#46;"
              "apellidos" => "Salgado"
            ]
            1 => array:2 [
              "nombre" => "M&#46;"
              "apellidos" => "Landa"
            ]
            2 => array:2 [
              "nombre" => "D&#46;"
              "apellidos" => "Masevicius"
            ]
            3 => array:2 [
              "nombre" => "S&#46;"
              "apellidos" => "Gianassi"
            ]
            4 => array:2 [
              "nombre" => "J&#46;E&#46;"
              "apellidos" => "San-Rom&#225;n"
            ]
            5 => array:2 [
              "nombre" => "L&#46;"
              "apellidos" => "Silva"
            ]
            6 => array:2 [
              "nombre" => "M&#46;"
              "apellidos" => "Gimenez"
            ]
            7 => array:2 [
              "nombre" => "O&#46;"
              "apellidos" => "Tejerina"
            ]
            8 => array:2 [
              "nombre" => "P&#46;"
              "apellidos" => "D&#237;az-Cisneros"
            ]
            9 => array:2 [
              "nombre" => "F&#46;"
              "apellidos" => "Ciccioli"
            ]
            10 => array:2 [
              "nombre" => "J&#46;L&#46;"
              "apellidos" => "do Pico"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0210569113001083"
        "doi" => "10.1016/j.medin.2013.04.007"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0210569113001083?idApp=WMIE"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173572714000332?idApp=WMIE"
    "url" => "/21735727/0000003800000005/v1_201406130020/S2173572714000332/v1_201406130020/en/main.assets"
  ]
  "en" => array:19 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Original</span>"
    "titulo" => "Protein C zymogen in adults with severe sepsis or septic shock"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "278"
        "paginaFinal" => "282"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "M&#46; Crivellari, S&#46; Silvetti, C&#46; Gerli, G&#46; Landoni, A&#46; Franco, T&#46; Bove, F&#46; Pappalardo, A&#46; Zangrillo"
        "autores" => array:8 [
          0 => array:2 [
            "nombre" => "M&#46;"
            "apellidos" => "Crivellari"
          ]
          1 => array:2 [
            "nombre" => "S&#46;"
            "apellidos" => "Silvetti"
          ]
          2 => array:2 [
            "nombre" => "C&#46;"
            "apellidos" => "Gerli"
          ]
          3 => array:4 [
            "nombre" => "G&#46;"
            "apellidos" => "Landoni"
            "email" => array:1 [
              0 => "landoni&#46;giovanni&#64;hsr&#46;it"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">¿</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          4 => array:2 [
            "nombre" => "A&#46;"
            "apellidos" => "Franco"
          ]
          5 => array:2 [
            "nombre" => "T&#46;"
            "apellidos" => "Bove"
          ]
          6 => array:2 [
            "nombre" => "F&#46;"
            "apellidos" => "Pappalardo"
          ]
          7 => array:2 [
            "nombre" => "A&#46;"
            "apellidos" => "Zangrillo"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Department of Anesthesia and Intensive Care&#44; San Raffaele Scientific Institute&#44; Milano&#44; Italy"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Zim&#243;geno de prote&#237;na C en adultos con sepsis grave o choque s&#233;ptico"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Fig&#46; 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 873
            "Ancho" => 1442
            "Tamanyo" => 78669
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Trend of protein C zymogen during the 72<span class="elsevierStyleHsp" style=""></span>h of administration&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Severe sepsis and septic shock are life-threatening medical emergencies and are among the most significant challenges in critical care&#46; Mortality rates approach 30&#8211;50&#37;&#44; and can be as high as 90&#37; when multiple organ dysfunctions ensue&#46;<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1&#44;2</span></a> Improvement in survival rates was achieved through early broad-spectrum antibiotic administration&#44; organ supportive therapy&#44; and&#44; until recently&#44; through Recombinant Human Activated Protein C &#40;rhAPC&#41; in selected patients at low risk of bleeding&#46; A recent randomized study showed that rhAPC did not significantly reduce mortality at 28 or 90 days&#44; as compared with placebo&#44; in patients with septic shock&#46;<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Protein C &#40;PC&#41; is the vitamin K-dependent zymogen of a serine protease with antithrombotic&#44; anti-inflammatory&#44; and profibrinolytic properties&#46;<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> Due to its action on the coagulation pathway&#44; rhAPC&#44; the active form of drug&#44; exposes treated patients to a serious hemorrhagic risk<a class="elsevierStyleCrossRefs" href="#bib0025"><span class="elsevierStyleSup">5&#8211;8</span></a> and its administration was subject to careful evaluation of the risk-to-benefit ratio&#46; Attempts were made to use protein C zymogen&#44; its &#8220;inactive&#8221; precursor&#44; endowed with anti-inflammatory activity but devoid of anticoagulant properties&#46; Among its advantages&#44; PC is activated &#8220;on demand&#8221; in sites of major thrombin formation&#44; and this is expected to limit or eliminate unwanted bleeding&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">Few case series have been published on adult septic patients receiving protein C zymogen&#46; We hereby describe the largest case series of adult patients with severe sepsis or septic shock receiving PC in a single center&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Patients and methods&#44; setting and study population</span><p id="par0020" class="elsevierStylePara elsevierViewall">After ethical committee approval and with patients&#8217; written consent&#44; we collected data from 23 adult patients with severe sepsis or septic shock admitted to two intensive care units &#40;ICU&#41; of San Raffaele Scientific Institute over a 2-year period&#46; Eleven of these 23 patients were already reported in other publications&#46;<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">9&#44;10</span></a> Inclusion criteria were represented by age &#62;18 years&#44; diagnosis of severe sepsis &#40;acute organ dysfunction secondary to documented or suspected infection&#41; or septic shock &#40;severe sepsis plus hypotension not reversed with fluid resuscitation&#41; and two or more organ failures due to sepsis of recent onset &#40;less than 48<span class="elsevierStyleHsp" style=""></span>h&#41;&#59; contraindication to receive rhAPC &#40;recent major surgery in most patients&#41;&#59; being admitted in the ICU&#46; Exclusion criteria were represented by known allergy to the study product and inclusion in other studies&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">In addition to current standard-of-care therapies for severe sepsis and septic shock&#44; patients received PC concentrates &#40;Ceprotin<span class="elsevierStyleSup">&#174;</span>&#44; Baxter&#44; Wien&#41; administered as a starting bolus &#40;50<span class="elsevierStyleHsp" style=""></span>IU&#47;kg&#41; plus a 3<span class="elsevierStyleHsp" style=""></span>IU&#47;kg&#47;h continuous infusion over 72<span class="elsevierStyleHsp" style=""></span>h&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">We measured plasma PC activity&#44; prothrombin time &#40;PT&#41;&#44; activated partial thromboplastin time &#40;aPTT&#41;&#44; Platelets &#40;PLTs&#41;&#44; C-reactive protein &#40;CRP&#41;&#44; white cell count &#40;WBC&#41;&#44; D-dimer and fibrinogen &#40;FG&#41; values at baseline&#44; at 6 and 12<span class="elsevierStyleHsp" style=""></span>h after PC concentrate administration&#44; then every 12<span class="elsevierStyleHsp" style=""></span>h for 60<span class="elsevierStyleHsp" style=""></span>h&#46; The sequential organ assessment failure &#40;SOFA&#41; score&#44; the Acute Physiology and Chronic Health Evaluation &#40;APACHE II&#41; score&#44; and the simplified acute physiology score &#40;SAPS II&#41; were recorded at baseline &#40;when patient received PC zymogen&#41;&#44; daily for 7 days&#46;</p><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Laboratory methods</span><p id="par0035" class="elsevierStylePara elsevierViewall">Serial venous samples &#40;4&#46;5<span class="elsevierStyleHsp" style=""></span>ml&#41; were collected in siliconized Vacutainer tubes &#40;Becton-Dickinson&#44; Plymouth&#44; UK&#41; containing &#40;0&#46;5<span class="elsevierStyleHsp" style=""></span>ml&#41; tri-sodium citrate &#40;0&#46;129<span class="elsevierStyleHsp" style=""></span>M&#41; and in tubes containing 0&#46;5<span class="elsevierStyleHsp" style=""></span>ml of a mixture of tri-sodium citrate and benzamidine&#8211;HCl &#40;200<span class="elsevierStyleHsp" style=""></span>mM&#41; at the following times&#58; before the bolus dose&#44; 6<span class="elsevierStyleHsp" style=""></span>h after bolus and every 12<span class="elsevierStyleHsp" style=""></span>h thereafter up to 72<span class="elsevierStyleHsp" style=""></span>h&#46; Within 1<span class="elsevierStyleHsp" style=""></span>h from collection&#44; platelet poor plasma was obtained by centrifugation for 10<span class="elsevierStyleHsp" style=""></span>min at 2000<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">g</span> at room temperature&#46; PT &#40;Hemoliance Recombiplastin&#44; Instrumentation Laboratory&#44; Lexington&#44; MA&#41;&#44; aPTT &#40;STA aPTT Kaolin&#44; Diagnostica Stago&#44; Asnier sur Seine&#44; France&#41;&#44; FG &#40;clotting assay&#44; STA Fibrinogen&#44; Stago&#41;&#44; and D-dimer &#40;STA Liatest D-D&#44; Stago&#41; determinations were performed on fresh citrated plasma samples with an automated coagulometer &#40;STA&#44; Stago&#41;&#46; Plasma aliquots were snap-frozen with methanol and dry ice and stored at &#8722;70<span class="elsevierStyleHsp" style=""></span>&#176;C for additional measurements in citrated plasma of PC anticoagulant activity &#40;STA Protein C&#44; Stago&#41;&#44; and antithrombin &#40;amidolytic activity&#44; STA Antithrombin&#44; Stago&#41;&#46; Blood samples collected in tri-sodium citrate and benzamidine&#8211;HCl were also centrifuged as described above with plasma aliquots snap-frozen and stored at &#8722;70<span class="elsevierStyleHsp" style=""></span>&#176;C&#46; Within one month&#44; prothrombin fragment 1<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>2 &#40;F1<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>2&#44; Enzygnost F1<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>2&#44; Dade-Behring&#44; Marburg&#41; and thrombin-antithrombin III complex &#40;TAT Enzygnost TAT micro&#44; Dade-Behring&#44; Marburg&#41; were measured with commercially available ELISA kits&#46;</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Statistics</span><p id="par0040" class="elsevierStylePara elsevierViewall">Collected data were analyzed through repeated measure ANOVA&#44; chi-square &#40;<span class="elsevierStyleItalic">&#967;</span><span class="elsevierStyleSup">2</span>&#41;&#44; and Friedman&#39;s test using SPSS<span class="elsevierStyleSup">&#174;</span> 13 statistical package &#40;Chicago&#44; Illinois&#41;&#46; The <span class="elsevierStyleItalic">Z</span>-test for two proportions was employed to compare expected versus observed mortality&#46; A <span class="elsevierStyleItalic">p</span>-value &#60;0&#46;05 was considered statistically significant&#46;</p></span></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Results</span><p id="par0045" class="elsevierStylePara elsevierViewall">We enrolled 23 consecutive patients with severe sepsis or septic shock&#46; Twenty-one &#40;91&#37;&#41; of them were surgical patients &#40;18 cardiac surgery and one each for thoracic&#44; vascular&#44; urologic and abdominal surgery&#41; and 1 patient presented to the emergency department with septic shock&#46; Mean patient age was 63<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>12 years &#40;range 25&#8211;77&#41; and 4 &#40;17&#37;&#41; were female&#46;</p><p id="par0050" class="elsevierStylePara elsevierViewall">All patients showed signs of sepsis-induced multiorgan dysfunction syndrome&#58; 22 patients had respiratory failure&#44; 16 had acute renal failure requiring renal replacement therapy and 16 had pharmacological sedation&#46; The average APACHE II was 25<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>5&#44; mean SAPS II was 58<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>14&#44; and mean SOFA score was 14<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2&#46; The timing from surgery &#40;or ICU admission&#41; to the first cultural sample was 5<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4&#46;7 days while the timing from surgery &#40;or ICU admission&#41; to PC administration was 7<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>5&#46;1 days&#46; Seventeen patients had single or multiple cultural examination &#40;in 4 patients the germs were identified in multiple sites and in 6 patients more than one germ was identified&#41;&#46; Blood culture &#40;8 patients&#41;&#44; bronchoalveolar lavage &#40;10 patients&#41; and urine culture &#40;2 patients&#41; were positive for the following germs&#58; <span class="elsevierStyleItalic">Staphylococcus</span> spp&#46; &#40;7 patients&#41;&#44; <span class="elsevierStyleItalic">Escherichia coli</span> &#40;6 patients&#41;&#44; <span class="elsevierStyleItalic">Acinetobacter</span> spp&#46; &#40;2 patients&#41;&#44; <span class="elsevierStyleItalic">Proteus</span>&#44; <span class="elsevierStyleItalic">Serratia marcescens</span>&#44; <span class="elsevierStyleItalic">Streptococcus</span> spp&#46;&#44; <span class="elsevierStyleItalic">Enterobacter cloacae</span>&#44; <span class="elsevierStyleItalic">Klebsiella pneumonia</span>&#44; <span class="elsevierStyleItalic">Citrobacter</span> and <span class="elsevierStyleItalic">Pseudomonas aeruginosa</span>&#46;</p><p id="par0055" class="elsevierStylePara elsevierViewall">Baseline plasma PC activity was 33<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>18&#37; &#91;normal values 65&#8211;140&#37;&#93;&#44; and increased to 66<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>22&#37; at 6<span class="elsevierStyleHsp" style=""></span>h after PC bolus &#40;<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#41;&#46; Afterwards&#44; it remained constantly within normal range values during PC concentrate continuous infusion and was 90<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>25&#37; at 72<span class="elsevierStyleHsp" style=""></span>h &#40;<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001 to baseline&#41; &#40;<a class="elsevierStyleCrossRef" href="#fig0005">Fig&#46; 1</a>&#41;&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0060" class="elsevierStylePara elsevierViewall">Changes in laboratory variables after protein C concentrate administration showed in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#46; A significantly increasing of ATIII values from 49<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>15 to 81<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>19 was observed at 60<span class="elsevierStyleHsp" style=""></span>h &#40;<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#46;04&#41;&#44; FG and fibrin D-dimer showed a trend toward reduction and PLT count tended to increase from 130 &#40;&#215;10<span class="elsevierStyleSup">9</span>&#47;l&#41;<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>121 &#40;&#215;10<span class="elsevierStyleSup">9</span>&#47;l&#41; to 120 &#40;&#215;10<span class="elsevierStyleSup">9</span>&#47;l&#41;<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>140 &#40;&#215;10<span class="elsevierStyleSup">9</span>&#47;l&#41; during the 60<span class="elsevierStyleHsp" style=""></span>h period&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0065" class="elsevierStylePara elsevierViewall">On the inflammatory viewpoint PCR values significantly decreased from 204<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>130&#46;1 to 59<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>63&#46;0 during 60<span class="elsevierStyleHsp" style=""></span>h &#40;<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;01&#41;&#46;</p><p id="par0070" class="elsevierStylePara elsevierViewall">We observed a rapid reduction of the SOFA &#40;from 14<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2 to 7<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4&#44; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#41; &#40;<a class="elsevierStyleCrossRef" href="#fig0010">Fig&#46; 2</a>&#41;&#44; the SAPS II &#40;from 58<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>14 to 37<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>12&#44; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#41;&#44; and the APACHE II &#40;from 25<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>5 to 14<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>6&#44; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#41; scores at 7 days&#46;</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0075" class="elsevierStylePara elsevierViewall">Septic shock mortality rates in the literature approach 60&#37; and the expected mortality in our sample population was 53<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>17&#37;&#46; The <span class="elsevierStyleItalic">Z</span>-test for two proportions evidenced a significant reduction between the expected mortality &#40;53&#37;&#41; and the observed mortality 30&#37; &#40;<span class="elsevierStyleItalic">Z</span> value<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>1&#46;99&#44; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#46;046&#41;&#46; In fact&#44; 7 patients of our sample died &#40;30&#37;&#41;&#44; all of them by refractory shock&#46; A post hoc analysis showed that the best results in terms of crude mortality were observed in the subgroup of 11 patients with a cardiac index &#8805;2&#46;5<span class="elsevierStyleHsp" style=""></span>L&#47;min&#47;m<span class="elsevierStyleSup">2</span>&#46; In that group&#44; only 1 patient &#40;9&#37;&#41; died &#40;<span class="elsevierStyleItalic">Z</span> value<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>3&#46;5&#44; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#41;&#46;</p><p id="par0080" class="elsevierStylePara elsevierViewall">We observed two cases of hemorrhagic cystitis&#44; respectively three days and two weeks after PC concentrate interruption&#46; One case of bilateral jugular vein thrombosis was recorded as well&#46; These phenomena could not be attributed to the drug administration&#46; No bleeding complication was reported&#46;</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Discussion</span><p id="par0085" class="elsevierStylePara elsevierViewall">To the best of our knowledge this is the largest case series ever reported on the use of PC zymogen&#46; In this study we showed a favorable effects on coagulation&#44; multiorgan function and survival in patients that received PC zymogen&#46;</p><p id="par0090" class="elsevierStylePara elsevierViewall">PC levels increased from 33<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>18&#37; to 66<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>22&#37; &#91;normal values 65&#8211;140&#37;&#93;&#44; at 6<span class="elsevierStyleHsp" style=""></span>h after PC bolus &#40;<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#41;&#44; and kept on increasing during the 72<span class="elsevierStyleHsp" style=""></span>h of administration &#40;<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001 to baseline&#41;&#46; Interestingly&#44; all our patients had low baseline levels of PC&#46; This finding is important because a low PC value is a strong predictor of unfavorable outcome<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">11&#8211;14</span></a> and septic patients are associated with increased morbidity and mortality&#46; Despite this baseline data we achieved a survival rate of 70&#37;&#46; Given the expected poor outcome on the basis of the score risks and our patients&#8217; PC activity&#44; the 70&#37; survival rate may indicate that perhaps a beneficial drug effect on survival is present&#46;</p><p id="par0095" class="elsevierStylePara elsevierViewall">In our patients PC levels increased at 6<span class="elsevierStyleHsp" style=""></span>h after PC bolus and remained constant thereafter&#44; furthermore ATIII levels significantly increased after drug administration&#46;</p><p id="par0100" class="elsevierStylePara elsevierViewall">We also reported clinical benefit as documented by the significant reduction in the indices of organ dysfunction &#40;the SOFA&#41;&#46; Finally patient mortality was 30&#37; versus the expected 53&#37; and this difference was even more evident if only septic patients with cardiac index &#8805;2&#46;5<span class="elsevierStyleHsp" style=""></span>L&#47;min&#47;m<span class="elsevierStyleSup">2</span> were considered &#40;mortality was 9&#37;&#41;&#46;</p><p id="par0105" class="elsevierStylePara elsevierViewall">Consistently with the findings of the largest adult case series &#40;20 patients&#41; published so far<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a> we achieved normalization of coagulation parameters as a increasing of ATIII&#44; as indicated by prompt raise of plasma PC activity within normal values&#44; and a decreasing of PCR levels&#59; an improvement of indices of organ dysfunction and a beneficial effect on patient survival&#46; Similar findings were noted in our previously published case series that included 9 of these 23 patients&#46;<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a> A recent systematic review on all the published case reports and case series of adult septic patients receiving PC suggested that mortality rates are low when receiving this drug&#46;<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a></p><p id="par0110" class="elsevierStylePara elsevierViewall">One interesting finding of our case series is that the beneficial effects on survival were more important in the patients with high cardiac output&#46; The results of our study are important especially in view of the paucity of drugs&#44; techniques or strategies that might reduce perioperative mortality in critically ill patients&#46;<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">16</span></a></p><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Limitations</span><p id="par0115" class="elsevierStylePara elsevierViewall">Although this is the largest case series of adult patients receiving PC ever published in literature&#44; the small sample size and the non randomized study design do not allow us to draw definitive conclusions on the beneficial effect of PC administration in severe sepsis or septic shock&#46; Furthermore&#44; we measured only PCR and not other inflammatory markers such as procalcitonin or interleukine-6&#46; On top of this&#44; we acknowledge that the diagnosis of sepsis after major surgery might be challenging and that SIRS without infection is to be taken into consideration&#46; Lastly&#44; in half of our patients sepsis was diagnosed in patients with ongoing LCOS&#44; a condition that is frequent after cardiac surgery and that can further confound the clinical picture of these patients&#46;</p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Conclusions</span><p id="par0120" class="elsevierStylePara elsevierViewall">The favorable effects on coagulation&#44; multiorgan function and survival suggest potential beneficial effects of PC concentrate on restoring homeostasis&#44; at least as coagulation is concerned&#44; and should raise interest in confirming our and others&#8217; promising results through a randomized clinical trial or at least case match studies&#46;</p></span></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Conflict of interest</span><p id="par0125" class="elsevierStylePara elsevierViewall">The authors declare no conflicts of interest&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:10 [
        0 => array:2 [
          "identificador" => "xres345756"
          "titulo" => array:5 [
            0 => "Abstract"
            1 => "Introduction"
            2 => "Design&#44; setting and participants"
            3 => "Results"
            4 => "Conclusion"
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec327356"
          "titulo" => "Keywords"
        ]
        2 => array:2 [
          "identificador" => "xres345755"
          "titulo" => array:5 [
            0 => "Resumen"
            1 => "Introducci&#243;n"
            2 => "Dise&#241;o&#44; &#225;mbito y participantes"
            3 => "Resultados"
            4 => "Conclusi&#243;n"
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec327357"
          "titulo" => "Palabras clave"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introduction"
        ]
        5 => array:3 [
          "identificador" => "sec0010"
          "titulo" => "Patients and methods&#44; setting and study population"
          "secciones" => array:2 [
            0 => array:2 [
              "identificador" => "sec0015"
              "titulo" => "Laboratory methods"
            ]
            1 => array:2 [
              "identificador" => "sec0020"
              "titulo" => "Statistics"
            ]
          ]
        ]
        6 => array:2 [
          "identificador" => "sec0025"
          "titulo" => "Results"
        ]
        7 => array:3 [
          "identificador" => "sec0030"
          "titulo" => "Discussion"
          "secciones" => array:2 [
            0 => array:2 [
              "identificador" => "sec0035"
              "titulo" => "Limitations"
            ]
            1 => array:2 [
              "identificador" => "sec0040"
              "titulo" => "Conclusions"
            ]
          ]
        ]
        8 => array:2 [
          "identificador" => "sec0045"
          "titulo" => "Conflict of interest"
        ]
        9 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2012-11-20"
    "fechaAceptado" => "2013-04-21"
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec327356"
          "palabras" => array:5 [
            0 => "Protein C zymogen"
            1 => "Bleeding"
            2 => "Sepsis"
            3 => "Intensive care"
            4 => "Critical care"
          ]
        ]
      ]
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec327357"
          "palabras" => array:5 [
            0 => "Zim&#243;geno de prote&#237;na C"
            1 => "Hemorragia"
            2 => "Sepsis"
            3 => "Cuidados intensivos"
            4 => "Cuidados cr&#237;ticos"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<span class="elsevierStyleSectionTitle" id="sect0015">Introduction</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Activated protein C is associated with a risk of bleeding and its effects on survival in septic shock patients are questionable&#46; Protein C zymogen has no risk of bleeding and improves the outcome of patients with septic shock&#46; We hereby describe the largest published case series of adult patients receiving protein C zymogen&#46;</p> <span class="elsevierStyleSectionTitle" id="sect0020">Design&#44; setting and participants</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">A prospective study on 23 adult patients with severe sepsis or septic shock&#44; two or more organ failures and at high risk for bleeding&#44; treated with protein C zymogen &#40;50<span class="elsevierStyleHsp" style=""></span>IU&#47;kg bolus followed by continuous infusion of 3<span class="elsevierStyleHsp" style=""></span>IU&#47;kg&#47;h for 72<span class="elsevierStyleHsp" style=""></span>h&#41;&#46;</p> <span class="elsevierStyleSectionTitle" id="sect0025">Results</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">The <span class="elsevierStyleItalic">Z</span>-test evidenced a significant reduction between the expected mortality &#40;53&#37;&#41; and the observed mortality 30&#37; &#40;<span class="elsevierStyleItalic">Z</span> value<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>1&#46;99&#44; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#46;046&#41; in our sample population&#46; Protein C levels increased from 34<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>18&#37; to 66<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>22&#37; at 6<span class="elsevierStyleHsp" style=""></span>h after PC bolus &#40;<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#41;&#44; and kept on increasing during 72<span class="elsevierStyleHsp" style=""></span>h of administration &#40;<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001 to baseline&#41;&#46; Sequential Organ Failure Assessment &#40;SOFA&#41;&#44; score of organ dysfunction&#44; decreased from baseline to 7 days after administration of protein C from 14<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2 to 7<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4 &#40;<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#41;&#46; No adverse event drug related was noted&#46;</p> <span class="elsevierStyleSectionTitle" id="sect0030">Conclusion</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Protein C zymogen administration is safe and its use in septic patients should be investigated through a randomized controlled trial&#46;</p>"
      ]
      "es" => array:2 [
        "titulo" => "Resumen"
        "resumen" => "<span class="elsevierStyleSectionTitle" id="sect0040">Introducci&#243;n</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">La prote&#237;na C activada se asocia a un elevado riesgo de hemorragia&#44; y sus efectos sobre la supervivencia en los pacientes con choque s&#233;ptico son cuestionables&#46; El zim&#243;geno de prote&#237;na C no presenta ning&#250;n riesgo de hemorragia&#44; y mejora los resultados en los pacientes con choque s&#233;ptico&#46; Describimos la serie de casos m&#225;s amplia publicada de pacientes adultos tratados con zim&#243;geno de prote&#237;na C&#46;</p> <span class="elsevierStyleSectionTitle" id="sect0045">Dise&#241;o&#44; &#225;mbito y participantes</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Se ha llevado a cabo un estudio prospectivo en el que han participado 23 adultos con sepsis grave o choque s&#233;ptico&#44; 2 o m&#225;s fallos org&#225;nicos&#44; y un elevado riesgo de hemorragia&#44; tratados con zim&#243;geno de prote&#237;na C &#40;dosis en bolo de 50<span class="elsevierStyleHsp" style=""></span>UI&#47;kg seguida de una infusi&#243;n continua de 3<span class="elsevierStyleHsp" style=""></span>UI&#47;kg&#47;h durante 72<span class="elsevierStyleHsp" style=""></span>h&#41;&#46;</p> <span class="elsevierStyleSectionTitle" id="sect0050">Resultados</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">La prueba Z puso de manifiesto una disminuci&#243;n significativa entre la mortalidad prevista &#40;53&#37;&#41;&#44; y la mortalidad observada 30&#37; &#40;valor Z<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>1&#44;99&#59; p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;046&#41; en nuestra serie&#46; Las concentraciones de prote&#237;na C incrementaron de 34<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>18&#37; a 66<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>22&#37; a las 6<span class="elsevierStyleHsp" style=""></span>h de la dosis en bolo &#40;p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;001&#41;&#44; y siguieron incrementando durante las 72<span class="elsevierStyleHsp" style=""></span>h siguientes a la administraci&#243;n &#40;p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;001 respecto a la situaci&#243;n basal&#41;&#46; La puntuaci&#243;n en la evaluaci&#243;n secuencial del fallo org&#225;nico &#40;SOFA&#41; disminuy&#243; entre la situaci&#243;n basal&#44; y 7 d&#237;as despu&#233;s de la administraci&#243;n de prote&#237;na C de 14<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2 a 7<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4 &#40;p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;001&#41;&#46; No se registraron reacciones farmacol&#243;gicas adversas&#46;</p> <span class="elsevierStyleSectionTitle" id="sect0055">Conclusi&#243;n</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">El zim&#243;geno de prote&#237;na Z deber&#237;a investigarse su utilizaci&#243;n en los pacientes con sepsis mediante un estudio aleatorizado y controlado&#46;</p>"
      ]
    ]
    "multimedia" => array:3 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Fig&#46; 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 873
            "Ancho" => 1442
            "Tamanyo" => 78669
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Trend of protein C zymogen during the 72<span class="elsevierStyleHsp" style=""></span>h of administration&#46;</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Fig&#46; 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 707
            "Ancho" => 1539
            "Tamanyo" => 77708
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Variation of Sequential Organ Failure Assessment &#40;SOFA&#41;&#44; score during and after protein C zymogen administration&#46;</p>"
        ]
      ]
      2 => array:7 [
        "identificador" => "tbl0005"
        "etiqueta" => "Table 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" style="border-bottom: 2px solid black">Before bolus&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" style="border-bottom: 2px solid black">After 6<span class="elsevierStyleHsp" style=""></span>h&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" style="border-bottom: 2px solid black">12<span class="elsevierStyleHsp" style=""></span>h&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" style="border-bottom: 2px solid black">24<span class="elsevierStyleHsp" style=""></span>h&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" style="border-bottom: 2px solid black">36<span class="elsevierStyleHsp" style=""></span>h&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" style="border-bottom: 2px solid black">48<span class="elsevierStyleHsp" style=""></span>h&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" style="border-bottom: 2px solid black">60<span class="elsevierStyleHsp" style=""></span>h&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">p</span> value&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">aPTT &#40;ratio&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">40<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>15&#46;0&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">41<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>17&#46;9&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">40<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>19&#46;4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">40<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>20&#46;3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">38<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>14&#46;4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">36<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>12&#46;0&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">33<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>10&#46;9&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;33&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">ATIII&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">49<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>14&#46;9&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">66<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>19&#46;2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">66<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>26&#46;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">56<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>21&#46;2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">67<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>23&#46;2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">72<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>13&#46;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">81<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>18&#46;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;04&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">D-dimer &#40;mg&#47;ml&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6&#46;0<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>5&#46;73&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">5&#46;6<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>5&#46;92&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">5&#46;0<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>6&#46;19&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6&#46;2<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>6&#46;38&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">4&#46;4<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2&#46;90&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6&#46;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#46;47&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">5&#46;2<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2&#46;37&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;46&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">FG &#40;mg&#47;dl&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">550<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>163&#46;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">526<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>204&#46;6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">626<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>209&#46;2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">672<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>116&#46;1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">717<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>120&#46;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">674<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>137&#46;0&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">654<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>134&#46;0&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;62&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">INR&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;5<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#46;6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;5<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#46;6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;5<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#46;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;4<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#46;4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;3<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#46;3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;3<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#46;3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;2<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#46;2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;08&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">PCR &#40;ng&#47;ml&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">204<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>130&#46;1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">171<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>85&#46;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">157<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>68&#46;3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">132<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>90&#46;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">112<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>59&#46;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">67<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>64&#46;4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">59<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>63&#46;0&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&#60;0&#46;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Platelet count &#40;&#215;10<span class="elsevierStyleSup">9</span>&#47;l&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">130<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>121&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">110<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>85&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">120<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>120&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">130<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>123&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">140<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>124&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">130<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>137&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">120<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>140&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;86&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">WBC counts &#40;&#215;10<span class="elsevierStyleSup">9</span>&#47;l&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">19<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>11&#46;1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">21<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>14&#46;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">20<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>11&#46;3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">22<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>12&#46;3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">22<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>17&#46;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">23<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>19&#46;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">23<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>21&#46;6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;97&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab515352.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Changes in laboratory variables throughout protein C concentrate administration&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:16 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The epidemiology of sepsis in the United States from 1979 through 2000"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "G&#46;S&#46; Martin"
                            1 => "D&#46;M&#46; Mannino"
                            2 => "S&#46; Eaton"
                            3 => "M&#46; Moss"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa022139"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2003"
                        "volumen" => "348"
                        "paginaInicial" => "1546"
                        "paginaFinal" => "1554"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12700374"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Epidemiology of severe sepsis in the United States&#58; analysis of incidence&#44; outcome and associated costs of care"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "D&#46;C&#46; Angus"
                            1 => "W&#46;T&#46; Linde-Zwirble"
                            2 => "J&#46; Lidicker"
                            3 => "G&#46; Clermont"
                            4 => "J&#46; Carcillo"
                            5 => "M&#46;R&#46; Pinsky"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Crit Care Med"
                        "fecha" => "2001"
                        "volumen" => "29"
                        "paginaInicial" => "1303"
                        "paginaFinal" => "1310"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11445675"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Drotrecogin alfa &#40;activated&#41; in adults with septic shock"
                      "autores" => array:1 [
                        0 => array:2 [
                          "colaboracion" => "For the PROWESS-SHOCK Study Group"
                          "etal" => false
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa1202290"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2012"
                        "volumen" => "366"
                        "paginaInicial" => "2055"
                        "paginaFinal" => "2064"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22616830"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The protein C anticoagulant pathway"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "C&#46;T&#46; Esmon"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Arterioscler Thromb"
                        "fecha" => "1992"
                        "volumen" => "12"
                        "paginaInicial" => "135"
                        "paginaFinal" => "145"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1311945"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and safety of recombinant human activated protein C for severe sepsis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "colaboracion" => "For the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis &#40;PROWESS&#41; Study Group"
                          "etal" => false
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJM200103083441001"
                      "Revista" => array:6 [
                        "tituloSerie" => "New Eng J Med"
                        "fecha" => "2001"
                        "volumen" => "344"
                        "paginaInicial" => "699"
                        "paginaFinal" => "709"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11236773"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Drotrecogin alfa &#40;activated&#41; for adults with severe sepsis and low risk of death"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "E&#46; Abraham"
                            1 => "P&#46;F&#46; Laterre"
                            2 => "R&#46; Garg"
                            3 => "H&#46; Levy"
                            4 => "D&#46; Talwar"
                            5 => "B&#46;L&#46; Trzaskoma"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa050935"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2005"
                        "volumen" => "353"
                        "paginaInicial" => "1332"
                        "paginaFinal" => "1341"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16192478"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Drotrecogin alfa &#40;activated&#41; treatment in severe sepsis from the global-label trial ENHANCE&#58; further evidence for survival and safety and implication for early treatment"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;L&#46; Vincent"
                            1 => "G&#46;R&#46; Bernard"
                            2 => "R&#46; Beale"
                            3 => "C&#46; Doig"
                            4 => "C&#46; Putensen"
                            5 => "J&#46;F&#46; Dhainaut"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Crit Care Med"
                        "fecha" => "2005"
                        "volumen" => "33"
                        "paginaInicial" => "2266"
                        "paginaFinal" => "2277"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16215381"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Evaluation the use of drotrecogin alfa activated in adult severe sepsis&#58; a Canadian multicenter observational study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "S&#46; Kanji"
                            1 => "M&#46;M&#46; Perreault"
                            2 => "C&#46; Chant"
                            3 => "D&#46; Williamson"
                            4 => "L&#46; Burry"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s00134-007-0555-9"
                      "Revista" => array:6 [
                        "tituloSerie" => "Intensive Care Med"
                        "fecha" => "2007"
                        "volumen" => "33"
                        "paginaInicial" => "517"
                        "paginaFinal" => "523"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17325837"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Human protein C zymogen concentrate in patients with severe sepsis and multiple organ failure after adult cardiac surgery"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Crivellari"
                            1 => "P&#46; Della Valle"
                            2 => "G&#46; Landoni"
                            3 => "F&#46; Pappalardo"
                            4 => "C&#46; Gerli"
                            5 => "E&#46; Bignami"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s00134-009-1584-3"
                      "Revista" => array:6 [
                        "tituloSerie" => "Intensive Care Med"
                        "fecha" => "2009"
                        "volumen" => "35"
                        "paginaInicial" => "1959"
                        "paginaFinal" => "1963"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19649614"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Human in protein C concentrates in adult septic patient"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "G&#46; Landoni"
                            1 => "M&#46; Crivellari"
                            2 => "G&#46; Monti"
                            3 => "C&#46; Gerli"
                            4 => "P&#46; Silvani"
                            5 => "A&#46; Zangrillo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Signa Vitae"
                        "fecha" => "2008"
                        "volumen" => "3"
                        "paginaInicial" => "13"
                        "paginaFinal" => "17"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Coagulation activation and tissue necrosis in meningococcal septic shock&#58; severely reduced protein C levels predict a high mortality"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "K&#46; Fijnvandraat"
                            1 => "B&#46; Derkx"
                            2 => "M&#46; Peters"
                            3 => "R&#46; Bijlmer"
                            4 => "A&#46; Sturk"
                            5 => "M&#46;H&#46; Prins"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Thromb Haemost"
                        "fecha" => "1995"
                        "volumen" => "73"
                        "paginaInicial" => "15"
                        "paginaFinal" => "20"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7740486"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Protein C&#47;activated protein C pathway&#58; overview of clinical trial results in severe sepsis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "J&#46;F&#46; Dhainaut"
                            1 => "S&#46;B&#46; Yan"
                            2 => "Y&#46;E&#46; Claessens"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:7 [
                        "tituloSerie" => "Crit Care Med"
                        "fecha" => "2004"
                        "volumen" => "32"
                        "numero" => "Suppl&#46;"
                        "paginaInicial" => "S194"
                        "paginaFinal" => "S201"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15118517"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Protein C levels as prognostic indicator of outcome in sepsis and related diseases"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "C&#46;J&#46; Fisher Jr&#46;"
                            1 => "S&#46;B&#46; Yan"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:7 [
                        "tituloSerie" => "Crit Care Med"
                        "fecha" => "2000"
                        "volumen" => "28"
                        "numero" => "Suppl&#46;"
                        "paginaInicial" => "S49"
                        "paginaFinal" => "S56"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11007198"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Severe protein C deficiency predicts early death in severe sepsis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "W&#46;L&#46; Macias"
                            1 => "D&#46;R&#46; Nelson"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:7 [
                        "tituloSerie" => "Crit Care Med"
                        "fecha" => "2004"
                        "volumen" => "32"
                        "numero" => "Suppl&#46;"
                        "paginaInicial" => "S223"
                        "paginaFinal" => "S228"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15118522"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Protein C concentrate to restore physiological values in adult septic patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "F&#46; Baratto"
                            1 => "F&#46; Michielan"
                            2 => "M&#46; Meroni"
                            3 => "A&#46; Dal Pal&#249;"
                            4 => "A&#46; Boscolo"
                            5 => "C&#46; Ori"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s00134-008-1140-6"
                      "Revista" => array:6 [
                        "tituloSerie" => "Intensive Care Med"
                        "fecha" => "2008"
                        "volumen" => "34"
                        "paginaInicial" => "1707"
                        "paginaFinal" => "1712"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18458873"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Mortality reduction in cardiac anesthesia and intensive care&#58; results of the first International Consensus Conference"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "G&#46; Landoni"
                            1 => "J&#46;G&#46; Augoustides"
                            2 => "F&#46; Guarracino"
                            3 => "F&#46; Santini"
                            4 => "M&#46; Ponschab"
                            5 => "D&#46; Pasero"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "HSR Proc Intensive Care Cardiovasc Anesth"
                        "fecha" => "2011"
                        "volumen" => "3"
                        "paginaInicial" => "9"
                        "paginaFinal" => "19"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23439940"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/21735727/0000003800000005/v1_201406130020/S2173572714000381/v1_201406130020/en/main.assets"
  "Apartado" => null
  "PDF" => "https://static.elsevier.es/multimedia/21735727/0000003800000005/v1_201406130020/S2173572714000381/v1_201406130020/en/main.pdf?idApp=WMIE&text.app=https://medintensiva.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173572714000381?idApp=WMIE"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Original
Protein C zymogen in adults with severe sepsis or septic shock
Zimógeno de proteína C en adultos con sepsis grave o choque séptico
M. Crivellari, S. Silvetti, C. Gerli, G. Landoni
Corresponding author
landoni.giovanni@hsr.it

Corresponding author.
, A. Franco, T. Bove, F. Pappalardo, A. Zangrillo
Department of Anesthesia and Intensive Care, San Raffaele Scientific Institute, Milano, Italy
Read
5787
Times
was read the article
2359
Total PDF
3428
Total HTML
Share statistics
 array:23 [
  "pii" => "S2173572714000381"
  "issn" => "21735727"
  "doi" => "10.1016/j.medine.2013.04.004"
  "estado" => "S300"
  "fechaPublicacion" => "2014-06-01"
  "aid" => "594"
  "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46; and SEMICYUC"
  "copyrightAnyo" => "2012"
  "documento" => "article"
  "crossmark" => 0
  "subdocumento" => "fla"
  "cita" => "Med Intensiva. 2014;38:278-82"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 2117
    "formatos" => array:3 [
      "EPUB" => 171
      "HTML" => 1223
      "PDF" => 723
    ]
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S2173572714000393"
    "issn" => "21735727"
    "doi" => "10.1016/j.medine.2013.06.003"
    "estado" => "S300"
    "fechaPublicacion" => "2014-06-01"
    "aid" => "605"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46; and SEMICYUC"
    "documento" => "article"
    "crossmark" => 0
    "subdocumento" => "fla"
    "cita" => "Med Intensiva. 2014;38:288-96"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2120
      "formatos" => array:3 [
        "EPUB" => 153
        "HTML" => 1270
        "PDF" => 697
      ]
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original</span>"
      "titulo" => "External validation of the Simplified Acute Physiology Score &#40;SAPS&#41; 3 in Spain"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "288"
          "paginaFinal" => "296"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Validaci&#243;n externa de la puntuaci&#243;n de fisiolog&#237;a aguda simplificada &#40;SAPS&#41; 3 en Espa&#241;a"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0020"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 2580
              "Ancho" => 1558
              "Tamanyo" => 109036
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">ROC curve&#46; Discrimination for Simplified Acute Physiology Score 3 model tested using the area under the Receiver Operating Characteristics curve &#40;ROC area&#41;&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "C&#46; L&#243;pez-Caler, M&#46; Garc&#237;a-Delgado, J&#46; Carpio-Sanz, J&#46; &#193;lvarez-Rodr&#237;guez, E&#46; Aguilar-Alonso, E&#46; Castillo-Lorente, J&#46;E&#46; Barrueco-Francioni, R&#46; Rivera-Fern&#225;ndez"
          "autores" => array:8 [
            0 => array:2 [
              "nombre" => "C&#46;"
              "apellidos" => "L&#243;pez-Caler"
            ]
            1 => array:2 [
              "nombre" => "M&#46;"
              "apellidos" => "Garc&#237;a-Delgado"
            ]
            2 => array:2 [
              "nombre" => "J&#46;"
              "apellidos" => "Carpio-Sanz"
            ]
            3 => array:2 [
              "nombre" => "J&#46;"
              "apellidos" => "&#193;lvarez-Rodr&#237;guez"
            ]
            4 => array:2 [
              "nombre" => "E&#46;"
              "apellidos" => "Aguilar-Alonso"
            ]
            5 => array:2 [
              "nombre" => "E&#46;"
              "apellidos" => "Castillo-Lorente"
            ]
            6 => array:2 [
              "nombre" => "J&#46;E&#46;"
              "apellidos" => "Barrueco-Francioni"
            ]
            7 => array:2 [
              "nombre" => "R&#46;"
              "apellidos" => "Rivera-Fern&#225;ndez"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173572714000393?idApp=WMIE"
    "url" => "/21735727/0000003800000005/v1_201406130020/S2173572714000393/v1_201406130020/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S2173572714000332"
    "issn" => "21735727"
    "doi" => "10.1016/j.medine.2013.04.003"
    "estado" => "S300"
    "fechaPublicacion" => "2014-06-01"
    "aid" => "596"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46; and SEMICYUC"
    "documento" => "article"
    "crossmark" => 0
    "subdocumento" => "fla"
    "cita" => "Med Intensiva. 2014;38:271-7"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 3804
      "formatos" => array:3 [
        "EPUB" => 172
        "HTML" => 2758
        "PDF" => 874
      ]
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original</span>"
      "titulo" => "Acute renal failure according to the RIFLE and AKIN criteria&#58; A multicenter study"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "271"
          "paginaFinal" => "277"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Insuficiencia renal aguda seg&#250;n RIFLE y AKIN&#58; estudio multic&#233;ntrico"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 971
              "Ancho" => 1547
              "Tamanyo" => 70390
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">Acute renal failure according to the AKIN and RIFLE classifications&#44; and both classifications jointly&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "G&#46; Salgado, M&#46; Landa, D&#46; Masevicius, S&#46; Gianassi, J&#46;E&#46; San-Rom&#225;n, L&#46; Silva, M&#46; Gimenez, O&#46; Tejerina, P&#46; D&#237;az-Cisneros, F&#46; Ciccioli, J&#46;L&#46; do Pico"
          "autores" => array:11 [
            0 => array:2 [
              "nombre" => "G&#46;"
              "apellidos" => "Salgado"
            ]
            1 => array:2 [
              "nombre" => "M&#46;"
              "apellidos" => "Landa"
            ]
            2 => array:2 [
              "nombre" => "D&#46;"
              "apellidos" => "Masevicius"
            ]
            3 => array:2 [
              "nombre" => "S&#46;"
              "apellidos" => "Gianassi"
            ]
            4 => array:2 [
              "nombre" => "J&#46;E&#46;"
              "apellidos" => "San-Rom&#225;n"
            ]
            5 => array:2 [
              "nombre" => "L&#46;"
              "apellidos" => "Silva"
            ]
            6 => array:2 [
              "nombre" => "M&#46;"
              "apellidos" => "Gimenez"
            ]
            7 => array:2 [
              "nombre" => "O&#46;"
              "apellidos" => "Tejerina"
            ]
            8 => array:2 [
              "nombre" => "P&#46;"
              "apellidos" => "D&#237;az-Cisneros"
            ]
            9 => array:2 [
              "nombre" => "F&#46;"
              "apellidos" => "Ciccioli"
            ]
            10 => array:2 [
              "nombre" => "J&#46;L&#46;"
              "apellidos" => "do Pico"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0210569113001083"
        "doi" => "10.1016/j.medin.2013.04.007"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0210569113001083?idApp=WMIE"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173572714000332?idApp=WMIE"
    "url" => "/21735727/0000003800000005/v1_201406130020/S2173572714000332/v1_201406130020/en/main.assets"
  ]
  "en" => array:19 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Original</span>"
    "titulo" => "Protein C zymogen in adults with severe sepsis or septic shock"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "278"
        "paginaFinal" => "282"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "M&#46; Crivellari, S&#46; Silvetti, C&#46; Gerli, G&#46; Landoni, A&#46; Franco, T&#46; Bove, F&#46; Pappalardo, A&#46; Zangrillo"
        "autores" => array:8 [
          0 => array:2 [
            "nombre" => "M&#46;"
            "apellidos" => "Crivellari"
          ]
          1 => array:2 [
            "nombre" => "S&#46;"
            "apellidos" => "Silvetti"
          ]
          2 => array:2 [
            "nombre" => "C&#46;"
            "apellidos" => "Gerli"
          ]
          3 => array:4 [
            "nombre" => "G&#46;"
            "apellidos" => "Landoni"
            "email" => array:1 [
              0 => "landoni&#46;giovanni&#64;hsr&#46;it"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">¿</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          4 => array:2 [
            "nombre" => "A&#46;"
            "apellidos" => "Franco"
          ]
          5 => array:2 [
            "nombre" => "T&#46;"
            "apellidos" => "Bove"
          ]
          6 => array:2 [
            "nombre" => "F&#46;"
            "apellidos" => "Pappalardo"
          ]
          7 => array:2 [
            "nombre" => "A&#46;"
            "apellidos" => "Zangrillo"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Department of Anesthesia and Intensive Care&#44; San Raffaele Scientific Institute&#44; Milano&#44; Italy"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Zim&#243;geno de prote&#237;na C en adultos con sepsis grave o choque s&#233;ptico"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Fig&#46; 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 873
            "Ancho" => 1442
            "Tamanyo" => 78669
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Trend of protein C zymogen during the 72<span class="elsevierStyleHsp" style=""></span>h of administration&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Severe sepsis and septic shock are life-threatening medical emergencies and are among the most significant challenges in critical care&#46; Mortality rates approach 30&#8211;50&#37;&#44; and can be as high as 90&#37; when multiple organ dysfunctions ensue&#46;<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1&#44;2</span></a> Improvement in survival rates was achieved through early broad-spectrum antibiotic administration&#44; organ supportive therapy&#44; and&#44; until recently&#44; through Recombinant Human Activated Protein C &#40;rhAPC&#41; in selected patients at low risk of bleeding&#46; A recent randomized study showed that rhAPC did not significantly reduce mortality at 28 or 90 days&#44; as compared with placebo&#44; in patients with septic shock&#46;<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Protein C &#40;PC&#41; is the vitamin K-dependent zymogen of a serine protease with antithrombotic&#44; anti-inflammatory&#44; and profibrinolytic properties&#46;<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> Due to its action on the coagulation pathway&#44; rhAPC&#44; the active form of drug&#44; exposes treated patients to a serious hemorrhagic risk<a class="elsevierStyleCrossRefs" href="#bib0025"><span class="elsevierStyleSup">5&#8211;8</span></a> and its administration was subject to careful evaluation of the risk-to-benefit ratio&#46; Attempts were made to use protein C zymogen&#44; its &#8220;inactive&#8221; precursor&#44; endowed with anti-inflammatory activity but devoid of anticoagulant properties&#46; Among its advantages&#44; PC is activated &#8220;on demand&#8221; in sites of major thrombin formation&#44; and this is expected to limit or eliminate unwanted bleeding&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">Few case series have been published on adult septic patients receiving protein C zymogen&#46; We hereby describe the largest case series of adult patients with severe sepsis or septic shock receiving PC in a single center&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Patients and methods&#44; setting and study population</span><p id="par0020" class="elsevierStylePara elsevierViewall">After ethical committee approval and with patients&#8217; written consent&#44; we collected data from 23 adult patients with severe sepsis or septic shock admitted to two intensive care units &#40;ICU&#41; of San Raffaele Scientific Institute over a 2-year period&#46; Eleven of these 23 patients were already reported in other publications&#46;<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">9&#44;10</span></a> Inclusion criteria were represented by age &#62;18 years&#44; diagnosis of severe sepsis &#40;acute organ dysfunction secondary to documented or suspected infection&#41; or septic shock &#40;severe sepsis plus hypotension not reversed with fluid resuscitation&#41; and two or more organ failures due to sepsis of recent onset &#40;less than 48<span class="elsevierStyleHsp" style=""></span>h&#41;&#59; contraindication to receive rhAPC &#40;recent major surgery in most patients&#41;&#59; being admitted in the ICU&#46; Exclusion criteria were represented by known allergy to the study product and inclusion in other studies&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">In addition to current standard-of-care therapies for severe sepsis and septic shock&#44; patients received PC concentrates &#40;Ceprotin<span class="elsevierStyleSup">&#174;</span>&#44; Baxter&#44; Wien&#41; administered as a starting bolus &#40;50<span class="elsevierStyleHsp" style=""></span>IU&#47;kg&#41; plus a 3<span class="elsevierStyleHsp" style=""></span>IU&#47;kg&#47;h continuous infusion over 72<span class="elsevierStyleHsp" style=""></span>h&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">We measured plasma PC activity&#44; prothrombin time &#40;PT&#41;&#44; activated partial thromboplastin time &#40;aPTT&#41;&#44; Platelets &#40;PLTs&#41;&#44; C-reactive protein &#40;CRP&#41;&#44; white cell count &#40;WBC&#41;&#44; D-dimer and fibrinogen &#40;FG&#41; values at baseline&#44; at 6 and 12<span class="elsevierStyleHsp" style=""></span>h after PC concentrate administration&#44; then every 12<span class="elsevierStyleHsp" style=""></span>h for 60<span class="elsevierStyleHsp" style=""></span>h&#46; The sequential organ assessment failure &#40;SOFA&#41; score&#44; the Acute Physiology and Chronic Health Evaluation &#40;APACHE II&#41; score&#44; and the simplified acute physiology score &#40;SAPS II&#41; were recorded at baseline &#40;when patient received PC zymogen&#41;&#44; daily for 7 days&#46;</p><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Laboratory methods</span><p id="par0035" class="elsevierStylePara elsevierViewall">Serial venous samples &#40;4&#46;5<span class="elsevierStyleHsp" style=""></span>ml&#41; were collected in siliconized Vacutainer tubes &#40;Becton-Dickinson&#44; Plymouth&#44; UK&#41; containing &#40;0&#46;5<span class="elsevierStyleHsp" style=""></span>ml&#41; tri-sodium citrate &#40;0&#46;129<span class="elsevierStyleHsp" style=""></span>M&#41; and in tubes containing 0&#46;5<span class="elsevierStyleHsp" style=""></span>ml of a mixture of tri-sodium citrate and benzamidine&#8211;HCl &#40;200<span class="elsevierStyleHsp" style=""></span>mM&#41; at the following times&#58; before the bolus dose&#44; 6<span class="elsevierStyleHsp" style=""></span>h after bolus and every 12<span class="elsevierStyleHsp" style=""></span>h thereafter up to 72<span class="elsevierStyleHsp" style=""></span>h&#46; Within 1<span class="elsevierStyleHsp" style=""></span>h from collection&#44; platelet poor plasma was obtained by centrifugation for 10<span class="elsevierStyleHsp" style=""></span>min at 2000<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">g</span> at room temperature&#46; PT &#40;Hemoliance Recombiplastin&#44; Instrumentation Laboratory&#44; Lexington&#44; MA&#41;&#44; aPTT &#40;STA aPTT Kaolin&#44; Diagnostica Stago&#44; Asnier sur Seine&#44; France&#41;&#44; FG &#40;clotting assay&#44; STA Fibrinogen&#44; Stago&#41;&#44; and D-dimer &#40;STA Liatest D-D&#44; Stago&#41; determinations were performed on fresh citrated plasma samples with an automated coagulometer &#40;STA&#44; Stago&#41;&#46; Plasma aliquots were snap-frozen with methanol and dry ice and stored at &#8722;70<span class="elsevierStyleHsp" style=""></span>&#176;C for additional measurements in citrated plasma of PC anticoagulant activity &#40;STA Protein C&#44; Stago&#41;&#44; and antithrombin &#40;amidolytic activity&#44; STA Antithrombin&#44; Stago&#41;&#46; Blood samples collected in tri-sodium citrate and benzamidine&#8211;HCl were also centrifuged as described above with plasma aliquots snap-frozen and stored at &#8722;70<span class="elsevierStyleHsp" style=""></span>&#176;C&#46; Within one month&#44; prothrombin fragment 1<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>2 &#40;F1<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>2&#44; Enzygnost F1<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>2&#44; Dade-Behring&#44; Marburg&#41; and thrombin-antithrombin III complex &#40;TAT Enzygnost TAT micro&#44; Dade-Behring&#44; Marburg&#41; were measured with commercially available ELISA kits&#46;</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Statistics</span><p id="par0040" class="elsevierStylePara elsevierViewall">Collected data were analyzed through repeated measure ANOVA&#44; chi-square &#40;<span class="elsevierStyleItalic">&#967;</span><span class="elsevierStyleSup">2</span>&#41;&#44; and Friedman&#39;s test using SPSS<span class="elsevierStyleSup">&#174;</span> 13 statistical package &#40;Chicago&#44; Illinois&#41;&#46; The <span class="elsevierStyleItalic">Z</span>-test for two proportions was employed to compare expected versus observed mortality&#46; A <span class="elsevierStyleItalic">p</span>-value &#60;0&#46;05 was considered statistically significant&#46;</p></span></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Results</span><p id="par0045" class="elsevierStylePara elsevierViewall">We enrolled 23 consecutive patients with severe sepsis or septic shock&#46; Twenty-one &#40;91&#37;&#41; of them were surgical patients &#40;18 cardiac surgery and one each for thoracic&#44; vascular&#44; urologic and abdominal surgery&#41; and 1 patient presented to the emergency department with septic shock&#46; Mean patient age was 63<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>12 years &#40;range 25&#8211;77&#41; and 4 &#40;17&#37;&#41; were female&#46;</p><p id="par0050" class="elsevierStylePara elsevierViewall">All patients showed signs of sepsis-induced multiorgan dysfunction syndrome&#58; 22 patients had respiratory failure&#44; 16 had acute renal failure requiring renal replacement therapy and 16 had pharmacological sedation&#46; The average APACHE II was 25<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>5&#44; mean SAPS II was 58<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>14&#44; and mean SOFA score was 14<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2&#46; The timing from surgery &#40;or ICU admission&#41; to the first cultural sample was 5<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4&#46;7 days while the timing from surgery &#40;or ICU admission&#41; to PC administration was 7<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>5&#46;1 days&#46; Seventeen patients had single or multiple cultural examination &#40;in 4 patients the germs were identified in multiple sites and in 6 patients more than one germ was identified&#41;&#46; Blood culture &#40;8 patients&#41;&#44; bronchoalveolar lavage &#40;10 patients&#41; and urine culture &#40;2 patients&#41; were positive for the following germs&#58; <span class="elsevierStyleItalic">Staphylococcus</span> spp&#46; &#40;7 patients&#41;&#44; <span class="elsevierStyleItalic">Escherichia coli</span> &#40;6 patients&#41;&#44; <span class="elsevierStyleItalic">Acinetobacter</span> spp&#46; &#40;2 patients&#41;&#44; <span class="elsevierStyleItalic">Proteus</span>&#44; <span class="elsevierStyleItalic">Serratia marcescens</span>&#44; <span class="elsevierStyleItalic">Streptococcus</span> spp&#46;&#44; <span class="elsevierStyleItalic">Enterobacter cloacae</span>&#44; <span class="elsevierStyleItalic">Klebsiella pneumonia</span>&#44; <span class="elsevierStyleItalic">Citrobacter</span> and <span class="elsevierStyleItalic">Pseudomonas aeruginosa</span>&#46;</p><p id="par0055" class="elsevierStylePara elsevierViewall">Baseline plasma PC activity was 33<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>18&#37; &#91;normal values 65&#8211;140&#37;&#93;&#44; and increased to 66<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>22&#37; at 6<span class="elsevierStyleHsp" style=""></span>h after PC bolus &#40;<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#41;&#46; Afterwards&#44; it remained constantly within normal range values during PC concentrate continuous infusion and was 90<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>25&#37; at 72<span class="elsevierStyleHsp" style=""></span>h &#40;<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001 to baseline&#41; &#40;<a class="elsevierStyleCrossRef" href="#fig0005">Fig&#46; 1</a>&#41;&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0060" class="elsevierStylePara elsevierViewall">Changes in laboratory variables after protein C concentrate administration showed in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#46; A significantly increasing of ATIII values from 49<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>15 to 81<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>19 was observed at 60<span class="elsevierStyleHsp" style=""></span>h &#40;<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#46;04&#41;&#44; FG and fibrin D-dimer showed a trend toward reduction and PLT count tended to increase from 130 &#40;&#215;10<span class="elsevierStyleSup">9</span>&#47;l&#41;<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>121 &#40;&#215;10<span class="elsevierStyleSup">9</span>&#47;l&#41; to 120 &#40;&#215;10<span class="elsevierStyleSup">9</span>&#47;l&#41;<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>140 &#40;&#215;10<span class="elsevierStyleSup">9</span>&#47;l&#41; during the 60<span class="elsevierStyleHsp" style=""></span>h period&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0065" class="elsevierStylePara elsevierViewall">On the inflammatory viewpoint PCR values significantly decreased from 204<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>130&#46;1 to 59<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>63&#46;0 during 60<span class="elsevierStyleHsp" style=""></span>h &#40;<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;01&#41;&#46;</p><p id="par0070" class="elsevierStylePara elsevierViewall">We observed a rapid reduction of the SOFA &#40;from 14<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2 to 7<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4&#44; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#41; &#40;<a class="elsevierStyleCrossRef" href="#fig0010">Fig&#46; 2</a>&#41;&#44; the SAPS II &#40;from 58<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>14 to 37<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>12&#44; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#41;&#44; and the APACHE II &#40;from 25<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>5 to 14<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>6&#44; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#41; scores at 7 days&#46;</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0075" class="elsevierStylePara elsevierViewall">Septic shock mortality rates in the literature approach 60&#37; and the expected mortality in our sample population was 53<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>17&#37;&#46; The <span class="elsevierStyleItalic">Z</span>-test for two proportions evidenced a significant reduction between the expected mortality &#40;53&#37;&#41; and the observed mortality 30&#37; &#40;<span class="elsevierStyleItalic">Z</span> value<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>1&#46;99&#44; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#46;046&#41;&#46; In fact&#44; 7 patients of our sample died &#40;30&#37;&#41;&#44; all of them by refractory shock&#46; A post hoc analysis showed that the best results in terms of crude mortality were observed in the subgroup of 11 patients with a cardiac index &#8805;2&#46;5<span class="elsevierStyleHsp" style=""></span>L&#47;min&#47;m<span class="elsevierStyleSup">2</span>&#46; In that group&#44; only 1 patient &#40;9&#37;&#41; died &#40;<span class="elsevierStyleItalic">Z</span> value<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>3&#46;5&#44; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#41;&#46;</p><p id="par0080" class="elsevierStylePara elsevierViewall">We observed two cases of hemorrhagic cystitis&#44; respectively three days and two weeks after PC concentrate interruption&#46; One case of bilateral jugular vein thrombosis was recorded as well&#46; These phenomena could not be attributed to the drug administration&#46; No bleeding complication was reported&#46;</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Discussion</span><p id="par0085" class="elsevierStylePara elsevierViewall">To the best of our knowledge this is the largest case series ever reported on the use of PC zymogen&#46; In this study we showed a favorable effects on coagulation&#44; multiorgan function and survival in patients that received PC zymogen&#46;</p><p id="par0090" class="elsevierStylePara elsevierViewall">PC levels increased from 33<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>18&#37; to 66<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>22&#37; &#91;normal values 65&#8211;140&#37;&#93;&#44; at 6<span class="elsevierStyleHsp" style=""></span>h after PC bolus &#40;<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#41;&#44; and kept on increasing during the 72<span class="elsevierStyleHsp" style=""></span>h of administration &#40;<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001 to baseline&#41;&#46; Interestingly&#44; all our patients had low baseline levels of PC&#46; This finding is important because a low PC value is a strong predictor of unfavorable outcome<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">11&#8211;14</span></a> and septic patients are associated with increased morbidity and mortality&#46; Despite this baseline data we achieved a survival rate of 70&#37;&#46; Given the expected poor outcome on the basis of the score risks and our patients&#8217; PC activity&#44; the 70&#37; survival rate may indicate that perhaps a beneficial drug effect on survival is present&#46;</p><p id="par0095" class="elsevierStylePara elsevierViewall">In our patients PC levels increased at 6<span class="elsevierStyleHsp" style=""></span>h after PC bolus and remained constant thereafter&#44; furthermore ATIII levels significantly increased after drug administration&#46;</p><p id="par0100" class="elsevierStylePara elsevierViewall">We also reported clinical benefit as documented by the significant reduction in the indices of organ dysfunction &#40;the SOFA&#41;&#46; Finally patient mortality was 30&#37; versus the expected 53&#37; and this difference was even more evident if only septic patients with cardiac index &#8805;2&#46;5<span class="elsevierStyleHsp" style=""></span>L&#47;min&#47;m<span class="elsevierStyleSup">2</span> were considered &#40;mortality was 9&#37;&#41;&#46;</p><p id="par0105" class="elsevierStylePara elsevierViewall">Consistently with the findings of the largest adult case series &#40;20 patients&#41; published so far<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a> we achieved normalization of coagulation parameters as a increasing of ATIII&#44; as indicated by prompt raise of plasma PC activity within normal values&#44; and a decreasing of PCR levels&#59; an improvement of indices of organ dysfunction and a beneficial effect on patient survival&#46; Similar findings were noted in our previously published case series that included 9 of these 23 patients&#46;<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a> A recent systematic review on all the published case reports and case series of adult septic patients receiving PC suggested that mortality rates are low when receiving this drug&#46;<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a></p><p id="par0110" class="elsevierStylePara elsevierViewall">One interesting finding of our case series is that the beneficial effects on survival were more important in the patients with high cardiac output&#46; The results of our study are important especially in view of the paucity of drugs&#44; techniques or strategies that might reduce perioperative mortality in critically ill patients&#46;<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">16</span></a></p><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Limitations</span><p id="par0115" class="elsevierStylePara elsevierViewall">Although this is the largest case series of adult patients receiving PC ever published in literature&#44; the small sample size and the non randomized study design do not allow us to draw definitive conclusions on the beneficial effect of PC administration in severe sepsis or septic shock&#46; Furthermore&#44; we measured only PCR and not other inflammatory markers such as procalcitonin or interleukine-6&#46; On top of this&#44; we acknowledge that the diagnosis of sepsis after major surgery might be challenging and that SIRS without infection is to be taken into consideration&#46; Lastly&#44; in half of our patients sepsis was diagnosed in patients with ongoing LCOS&#44; a condition that is frequent after cardiac surgery and that can further confound the clinical picture of these patients&#46;</p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Conclusions</span><p id="par0120" class="elsevierStylePara elsevierViewall">The favorable effects on coagulation&#44; multiorgan function and survival suggest potential beneficial effects of PC concentrate on restoring homeostasis&#44; at least as coagulation is concerned&#44; and should raise interest in confirming our and others&#8217; promising results through a randomized clinical trial or at least case match studies&#46;</p></span></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Conflict of interest</span><p id="par0125" class="elsevierStylePara elsevierViewall">The authors declare no conflicts of interest&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:10 [
        0 => array:2 [
          "identificador" => "xres345756"
          "titulo" => array:5 [
            0 => "Abstract"
            1 => "Introduction"
            2 => "Design&#44; setting and participants"
            3 => "Results"
            4 => "Conclusion"
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec327356"
          "titulo" => "Keywords"
        ]
        2 => array:2 [
          "identificador" => "xres345755"
          "titulo" => array:5 [
            0 => "Resumen"
            1 => "Introducci&#243;n"
            2 => "Dise&#241;o&#44; &#225;mbito y participantes"
            3 => "Resultados"
            4 => "Conclusi&#243;n"
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec327357"
          "titulo" => "Palabras clave"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introduction"
        ]
        5 => array:3 [
          "identificador" => "sec0010"
          "titulo" => "Patients and methods&#44; setting and study population"
          "secciones" => array:2 [
            0 => array:2 [
              "identificador" => "sec0015"
              "titulo" => "Laboratory methods"
            ]
            1 => array:2 [
              "identificador" => "sec0020"
              "titulo" => "Statistics"
            ]
          ]
        ]
        6 => array:2 [
          "identificador" => "sec0025"
          "titulo" => "Results"
        ]
        7 => array:3 [
          "identificador" => "sec0030"
          "titulo" => "Discussion"
          "secciones" => array:2 [
            0 => array:2 [
              "identificador" => "sec0035"
              "titulo" => "Limitations"
            ]
            1 => array:2 [
              "identificador" => "sec0040"
              "titulo" => "Conclusions"
            ]
          ]
        ]
        8 => array:2 [
          "identificador" => "sec0045"
          "titulo" => "Conflict of interest"
        ]
        9 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2012-11-20"
    "fechaAceptado" => "2013-04-21"
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec327356"
          "palabras" => array:5 [
            0 => "Protein C zymogen"
            1 => "Bleeding"
            2 => "Sepsis"
            3 => "Intensive care"
            4 => "Critical care"
          ]
        ]
      ]
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec327357"
          "palabras" => array:5 [
            0 => "Zim&#243;geno de prote&#237;na C"
            1 => "Hemorragia"
            2 => "Sepsis"
            3 => "Cuidados intensivos"
            4 => "Cuidados cr&#237;ticos"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<span class="elsevierStyleSectionTitle" id="sect0015">Introduction</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Activated protein C is associated with a risk of bleeding and its effects on survival in septic shock patients are questionable&#46; Protein C zymogen has no risk of bleeding and improves the outcome of patients with septic shock&#46; We hereby describe the largest published case series of adult patients receiving protein C zymogen&#46;</p> <span class="elsevierStyleSectionTitle" id="sect0020">Design&#44; setting and participants</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">A prospective study on 23 adult patients with severe sepsis or septic shock&#44; two or more organ failures and at high risk for bleeding&#44; treated with protein C zymogen &#40;50<span class="elsevierStyleHsp" style=""></span>IU&#47;kg bolus followed by continuous infusion of 3<span class="elsevierStyleHsp" style=""></span>IU&#47;kg&#47;h for 72<span class="elsevierStyleHsp" style=""></span>h&#41;&#46;</p> <span class="elsevierStyleSectionTitle" id="sect0025">Results</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">The <span class="elsevierStyleItalic">Z</span>-test evidenced a significant reduction between the expected mortality &#40;53&#37;&#41; and the observed mortality 30&#37; &#40;<span class="elsevierStyleItalic">Z</span> value<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>1&#46;99&#44; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#46;046&#41; in our sample population&#46; Protein C levels increased from 34<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>18&#37; to 66<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>22&#37; at 6<span class="elsevierStyleHsp" style=""></span>h after PC bolus &#40;<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#41;&#44; and kept on increasing during 72<span class="elsevierStyleHsp" style=""></span>h of administration &#40;<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001 to baseline&#41;&#46; Sequential Organ Failure Assessment &#40;SOFA&#41;&#44; score of organ dysfunction&#44; decreased from baseline to 7 days after administration of protein C from 14<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2 to 7<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4 &#40;<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#41;&#46; No adverse event drug related was noted&#46;</p> <span class="elsevierStyleSectionTitle" id="sect0030">Conclusion</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Protein C zymogen administration is safe and its use in septic patients should be investigated through a randomized controlled trial&#46;</p>"
      ]
      "es" => array:2 [
        "titulo" => "Resumen"
        "resumen" => "<span class="elsevierStyleSectionTitle" id="sect0040">Introducci&#243;n</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">La prote&#237;na C activada se asocia a un elevado riesgo de hemorragia&#44; y sus efectos sobre la supervivencia en los pacientes con choque s&#233;ptico son cuestionables&#46; El zim&#243;geno de prote&#237;na C no presenta ning&#250;n riesgo de hemorragia&#44; y mejora los resultados en los pacientes con choque s&#233;ptico&#46; Describimos la serie de casos m&#225;s amplia publicada de pacientes adultos tratados con zim&#243;geno de prote&#237;na C&#46;</p> <span class="elsevierStyleSectionTitle" id="sect0045">Dise&#241;o&#44; &#225;mbito y participantes</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Se ha llevado a cabo un estudio prospectivo en el que han participado 23 adultos con sepsis grave o choque s&#233;ptico&#44; 2 o m&#225;s fallos org&#225;nicos&#44; y un elevado riesgo de hemorragia&#44; tratados con zim&#243;geno de prote&#237;na C &#40;dosis en bolo de 50<span class="elsevierStyleHsp" style=""></span>UI&#47;kg seguida de una infusi&#243;n continua de 3<span class="elsevierStyleHsp" style=""></span>UI&#47;kg&#47;h durante 72<span class="elsevierStyleHsp" style=""></span>h&#41;&#46;</p> <span class="elsevierStyleSectionTitle" id="sect0050">Resultados</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">La prueba Z puso de manifiesto una disminuci&#243;n significativa entre la mortalidad prevista &#40;53&#37;&#41;&#44; y la mortalidad observada 30&#37; &#40;valor Z<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>1&#44;99&#59; p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;046&#41; en nuestra serie&#46; Las concentraciones de prote&#237;na C incrementaron de 34<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>18&#37; a 66<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>22&#37; a las 6<span class="elsevierStyleHsp" style=""></span>h de la dosis en bolo &#40;p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;001&#41;&#44; y siguieron incrementando durante las 72<span class="elsevierStyleHsp" style=""></span>h siguientes a la administraci&#243;n &#40;p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;001 respecto a la situaci&#243;n basal&#41;&#46; La puntuaci&#243;n en la evaluaci&#243;n secuencial del fallo org&#225;nico &#40;SOFA&#41; disminuy&#243; entre la situaci&#243;n basal&#44; y 7 d&#237;as despu&#233;s de la administraci&#243;n de prote&#237;na C de 14<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2 a 7<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4 &#40;p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;001&#41;&#46; No se registraron reacciones farmacol&#243;gicas adversas&#46;</p> <span class="elsevierStyleSectionTitle" id="sect0055">Conclusi&#243;n</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">El zim&#243;geno de prote&#237;na Z deber&#237;a investigarse su utilizaci&#243;n en los pacientes con sepsis mediante un estudio aleatorizado y controlado&#46;</p>"
      ]
    ]
    "multimedia" => array:3 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Fig&#46; 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 873
            "Ancho" => 1442
            "Tamanyo" => 78669
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Trend of protein C zymogen during the 72<span class="elsevierStyleHsp" style=""></span>h of administration&#46;</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Fig&#46; 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 707
            "Ancho" => 1539
            "Tamanyo" => 77708
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Variation of Sequential Organ Failure Assessment &#40;SOFA&#41;&#44; score during and after protein C zymogen administration&#46;</p>"
        ]
      ]
      2 => array:7 [
        "identificador" => "tbl0005"
        "etiqueta" => "Table 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" style="border-bottom: 2px solid black">Before bolus&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" style="border-bottom: 2px solid black">After 6<span class="elsevierStyleHsp" style=""></span>h&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" style="border-bottom: 2px solid black">12<span class="elsevierStyleHsp" style=""></span>h&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" style="border-bottom: 2px solid black">24<span class="elsevierStyleHsp" style=""></span>h&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" style="border-bottom: 2px solid black">36<span class="elsevierStyleHsp" style=""></span>h&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" style="border-bottom: 2px solid black">48<span class="elsevierStyleHsp" style=""></span>h&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" style="border-bottom: 2px solid black">60<span class="elsevierStyleHsp" style=""></span>h&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">p</span> value&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">aPTT &#40;ratio&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">40<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>15&#46;0&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">41<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>17&#46;9&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">40<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>19&#46;4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">40<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>20&#46;3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">38<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>14&#46;4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">36<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>12&#46;0&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">33<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>10&#46;9&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;33&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">ATIII&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">49<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>14&#46;9&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">66<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>19&#46;2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">66<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>26&#46;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">56<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>21&#46;2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">67<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>23&#46;2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">72<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>13&#46;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">81<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>18&#46;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;04&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">D-dimer &#40;mg&#47;ml&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6&#46;0<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>5&#46;73&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">5&#46;6<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>5&#46;92&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">5&#46;0<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>6&#46;19&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6&#46;2<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>6&#46;38&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">4&#46;4<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2&#46;90&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6&#46;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#46;47&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">5&#46;2<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2&#46;37&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;46&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">FG &#40;mg&#47;dl&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">550<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>163&#46;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">526<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>204&#46;6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">626<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>209&#46;2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">672<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>116&#46;1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">717<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>120&#46;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">674<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>137&#46;0&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">654<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>134&#46;0&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;62&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">INR&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;5<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#46;6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;5<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#46;6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;5<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#46;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;4<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#46;4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;3<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#46;3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;3<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#46;3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;2<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#46;2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;08&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">PCR &#40;ng&#47;ml&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">204<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>130&#46;1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">171<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>85&#46;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">157<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>68&#46;3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">132<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>90&#46;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">112<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>59&#46;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">67<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>64&#46;4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">59<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>63&#46;0&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&#60;0&#46;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Platelet count &#40;&#215;10<span class="elsevierStyleSup">9</span>&#47;l&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">130<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>121&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">110<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>85&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">120<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>120&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">130<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>123&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">140<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>124&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">130<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>137&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">120<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>140&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;86&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">WBC counts &#40;&#215;10<span class="elsevierStyleSup">9</span>&#47;l&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">19<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>11&#46;1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">21<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>14&#46;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">20<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>11&#46;3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">22<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>12&#46;3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">22<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>17&#46;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">23<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>19&#46;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">23<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>21&#46;6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;97&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab515352.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Changes in laboratory variables throughout protein C concentrate administration&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:16 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The epidemiology of sepsis in the United States from 1979 through 2000"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "G&#46;S&#46; Martin"
                            1 => "D&#46;M&#46; Mannino"
                            2 => "S&#46; Eaton"
                            3 => "M&#46; Moss"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa022139"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2003"
                        "volumen" => "348"
                        "paginaInicial" => "1546"
                        "paginaFinal" => "1554"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12700374"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Epidemiology of severe sepsis in the United States&#58; analysis of incidence&#44; outcome and associated costs of care"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "D&#46;C&#46; Angus"
                            1 => "W&#46;T&#46; Linde-Zwirble"
                            2 => "J&#46; Lidicker"
                            3 => "G&#46; Clermont"
                            4 => "J&#46; Carcillo"
                            5 => "M&#46;R&#46; Pinsky"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Crit Care Med"
                        "fecha" => "2001"
                        "volumen" => "29"
                        "paginaInicial" => "1303"
                        "paginaFinal" => "1310"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11445675"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Drotrecogin alfa &#40;activated&#41; in adults with septic shock"
                      "autores" => array:1 [
                        0 => array:2 [
                          "colaboracion" => "For the PROWESS-SHOCK Study Group"
                          "etal" => false
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa1202290"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2012"
                        "volumen" => "366"
                        "paginaInicial" => "2055"
                        "paginaFinal" => "2064"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22616830"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The protein C anticoagulant pathway"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "C&#46;T&#46; Esmon"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Arterioscler Thromb"
                        "fecha" => "1992"
                        "volumen" => "12"
                        "paginaInicial" => "135"
                        "paginaFinal" => "145"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1311945"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and safety of recombinant human activated protein C for severe sepsis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "colaboracion" => "For the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis &#40;PROWESS&#41; Study Group"
                          "etal" => false
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJM200103083441001"
                      "Revista" => array:6 [
                        "tituloSerie" => "New Eng J Med"
                        "fecha" => "2001"
                        "volumen" => "344"
                        "paginaInicial" => "699"
                        "paginaFinal" => "709"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11236773"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Drotrecogin alfa &#40;activated&#41; for adults with severe sepsis and low risk of death"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "E&#46; Abraham"
                            1 => "P&#46;F&#46; Laterre"
                            2 => "R&#46; Garg"
                            3 => "H&#46; Levy"
                            4 => "D&#46; Talwar"
                            5 => "B&#46;L&#46; Trzaskoma"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa050935"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2005"
                        "volumen" => "353"
                        "paginaInicial" => "1332"
                        "paginaFinal" => "1341"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16192478"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Drotrecogin alfa &#40;activated&#41; treatment in severe sepsis from the global-label trial ENHANCE&#58; further evidence for survival and safety and implication for early treatment"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;L&#46; Vincent"
                            1 => "G&#46;R&#46; Bernard"
                            2 => "R&#46; Beale"
                            3 => "C&#46; Doig"
                            4 => "C&#46; Putensen"
                            5 => "J&#46;F&#46; Dhainaut"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Crit Care Med"
                        "fecha" => "2005"
                        "volumen" => "33"
                        "paginaInicial" => "2266"
                        "paginaFinal" => "2277"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16215381"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Evaluation the use of drotrecogin alfa activated in adult severe sepsis&#58; a Canadian multicenter observational study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "S&#46; Kanji"
                            1 => "M&#46;M&#46; Perreault"
                            2 => "C&#46; Chant"
                            3 => "D&#46; Williamson"
                            4 => "L&#46; Burry"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s00134-007-0555-9"
                      "Revista" => array:6 [
                        "tituloSerie" => "Intensive Care Med"
                        "fecha" => "2007"
                        "volumen" => "33"
                        "paginaInicial" => "517"
                        "paginaFinal" => "523"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17325837"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Human protein C zymogen concentrate in patients with severe sepsis and multiple organ failure after adult cardiac surgery"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Crivellari"
                            1 => "P&#46; Della Valle"
                            2 => "G&#46; Landoni"
                            3 => "F&#46; Pappalardo"
                            4 => "C&#46; Gerli"
                            5 => "E&#46; Bignami"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s00134-009-1584-3"
                      "Revista" => array:6 [
                        "tituloSerie" => "Intensive Care Med"
                        "fecha" => "2009"
                        "volumen" => "35"
                        "paginaInicial" => "1959"
                        "paginaFinal" => "1963"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19649614"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Human in protein C concentrates in adult septic patient"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "G&#46; Landoni"
                            1 => "M&#46; Crivellari"
                            2 => "G&#46; Monti"
                            3 => "C&#46; Gerli"
                            4 => "P&#46; Silvani"
                            5 => "A&#46; Zangrillo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Signa Vitae"
                        "fecha" => "2008"
                        "volumen" => "3"
                        "paginaInicial" => "13"
                        "paginaFinal" => "17"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Coagulation activation and tissue necrosis in meningococcal septic shock&#58; severely reduced protein C levels predict a high mortality"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "K&#46; Fijnvandraat"
                            1 => "B&#46; Derkx"
                            2 => "M&#46; Peters"
                            3 => "R&#46; Bijlmer"
                            4 => "A&#46; Sturk"
                            5 => "M&#46;H&#46; Prins"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Thromb Haemost"
                        "fecha" => "1995"
                        "volumen" => "73"
                        "paginaInicial" => "15"
                        "paginaFinal" => "20"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7740486"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Protein C&#47;activated protein C pathway&#58; overview of clinical trial results in severe sepsis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "J&#46;F&#46; Dhainaut"
                            1 => "S&#46;B&#46; Yan"
                            2 => "Y&#46;E&#46; Claessens"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:7 [
                        "tituloSerie" => "Crit Care Med"
                        "fecha" => "2004"
                        "volumen" => "32"
                        "numero" => "Suppl&#46;"
                        "paginaInicial" => "S194"
                        "paginaFinal" => "S201"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15118517"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Protein C levels as prognostic indicator of outcome in sepsis and related diseases"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "C&#46;J&#46; Fisher Jr&#46;"
                            1 => "S&#46;B&#46; Yan"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:7 [
                        "tituloSerie" => "Crit Care Med"
                        "fecha" => "2000"
                        "volumen" => "28"
                        "numero" => "Suppl&#46;"
                        "paginaInicial" => "S49"
                        "paginaFinal" => "S56"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11007198"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Severe protein C deficiency predicts early death in severe sepsis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "W&#46;L&#46; Macias"
                            1 => "D&#46;R&#46; Nelson"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:7 [
                        "tituloSerie" => "Crit Care Med"
                        "fecha" => "2004"
                        "volumen" => "32"
                        "numero" => "Suppl&#46;"
                        "paginaInicial" => "S223"
                        "paginaFinal" => "S228"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15118522"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Protein C concentrate to restore physiological values in adult septic patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "F&#46; Baratto"
                            1 => "F&#46; Michielan"
                            2 => "M&#46; Meroni"
                            3 => "A&#46; Dal Pal&#249;"
                            4 => "A&#46; Boscolo"
                            5 => "C&#46; Ori"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s00134-008-1140-6"
                      "Revista" => array:6 [
                        "tituloSerie" => "Intensive Care Med"
                        "fecha" => "2008"
                        "volumen" => "34"
                        "paginaInicial" => "1707"
                        "paginaFinal" => "1712"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18458873"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Mortality reduction in cardiac anesthesia and intensive care&#58; results of the first International Consensus Conference"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "G&#46; Landoni"
                            1 => "J&#46;G&#46; Augoustides"
                            2 => "F&#46; Guarracino"
                            3 => "F&#46; Santini"
                            4 => "M&#46; Ponschab"
                            5 => "D&#46; Pasero"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "HSR Proc Intensive Care Cardiovasc Anesth"
                        "fecha" => "2011"
                        "volumen" => "3"
                        "paginaInicial" => "9"
                        "paginaFinal" => "19"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23439940"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/21735727/0000003800000005/v1_201406130020/S2173572714000381/v1_201406130020/en/main.assets"
  "Apartado" => null
  "PDF" => "https://static.elsevier.es/multimedia/21735727/0000003800000005/v1_201406130020/S2173572714000381/v1_201406130020/en/main.pdf?idApp=WMIE&text.app=https://medintensiva.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173572714000381?idApp=WMIE"
]
Article information
ISSN: 21735727
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 13 14 27
2024 October 73 43 116
2024 September 72 36 108
2024 August 58 36 94
2024 July 47 20 67
2024 June 33 44 77
2024 May 61 34 95
2024 April 44 31 75
2024 March 41 24 65
2024 February 32 32 64
2024 January 35 30 65
2023 December 33 38 71
2023 November 32 33 65
2023 October 26 22 48
2023 September 29 26 55
2023 August 29 11 40
2023 July 44 21 65
2023 June 44 15 59
2023 May 45 30 75
2023 April 53 18 71
2023 March 52 31 83
2023 February 50 29 79
2023 January 21 19 40
2022 December 37 26 63
2022 November 30 26 56
2022 October 52 35 87
2022 September 42 31 73
2022 August 44 32 76
2022 July 32 32 64
2022 June 35 23 58
2022 May 42 44 86
2022 April 32 32 64
2022 March 51 46 97
2022 February 26 22 48
2022 January 43 30 73
2021 December 32 45 77
2021 November 26 37 63
2021 October 54 63 117
2021 September 25 31 56
2021 August 21 31 52
2021 July 26 28 54
2021 June 25 17 42
2021 May 48 43 91
2021 April 75 54 129
2021 March 66 37 103
2021 February 49 25 74
2021 January 50 24 74
2020 December 30 30 60
2020 November 21 20 41
2020 October 29 24 53
2020 September 28 14 42
2020 August 22 13 35
2020 July 16 20 36
2020 June 40 11 51
2020 May 26 11 37
2020 April 34 25 59
2020 March 16 8 24
2020 February 60 55 115
2020 January 30 26 56
2019 December 35 27 62
2019 November 23 24 47
2019 October 38 16 54
2019 September 28 19 47
2019 August 27 23 50
2019 July 32 22 54
2019 June 15 9 24
2019 May 54 26 80
2019 April 38 12 50
2019 March 37 21 58
2019 February 32 39 71
2019 January 37 52 89
2018 December 79 32 111
2018 November 65 52 117
2018 October 58 32 90
2018 September 14 5 19
2018 August 13 6 19
2018 July 19 8 27
2018 June 17 8 25
2018 May 11 5 16
2018 April 19 8 27
2018 March 15 3 18
2018 February 14 5 19
2018 January 24 11 35
2017 December 17 9 26
2017 November 23 9 32
2017 October 12 7 19
2017 September 18 10 28
2017 August 8 10 18
2017 July 11 16 27
2017 June 20 14 34
2017 May 18 14 32
2017 April 25 14 39
2017 March 10 4 14
2017 February 19 15 34
2017 January 10 4 14
2016 December 27 9 36
2016 November 38 9 47
2016 October 42 15 57
2016 September 54 11 65
2016 August 31 8 39
2016 July 17 8 25
2015 December 2 0 2
Show all

Follow this link to access the full text of the article

Idiomas
Medicina Intensiva (English Edition)
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?